Dr. André Schmidt
- Specialist in Information Technology Law
Expertise
- IT Law
- Data Privacy Law
- Competition Law/ Fair Trading Law
- Intellectual Property Law (Trademark Law, Patent Law, Design Law)
- Media Law and Press Law
Reputation
- Handelsblatt & Best Lawyers 2020: Dr. André Schmidt is one of the best lawyers in the field of Intellectual Property Law in Germany
- Handelsblatt & Best Lawyers 2019: Dr. André Schmidt is one of the best lawyers in the field of Intellectual Property Law in Germany
Career
- 2000–2005 studied law at the Humboldt-University Berlin
- 2006–2008 legal traineeship in Berlin
- 2007–2008 secondary employment at the legal department of a mail-order companie
- Admitted to the bar in 2008
- 2008–2016 lawyer in an international major law firm
- Obtained law doctorate in Freiburg
- Since 2014 specialist in information technology law
- Since 2015 mentor at the Cyber Law Clinic of the University Hamburg
- Since 2016 lecturer at the HSB Akademie
- Joined LUTZ | ABEL in 2016
- Since 2020 lecturer at Macromedia University of Applied Sciences Hamburg
Memberships
- Deutsche Vereinigung für Gewerblichen Rechtsschutz und Urheberrecht e.V. (GRUR) (German Confederation for Intellectual Property Rights and Copyright Protection)
- Hamburgischer Anwaltsverein e.V. (Hamburg Bar Association)
- GDD Gesellschaft für Datenschutz und Datensicherheit e.V. (Society for data protection and data security)
- IAPP (International Association of Privacy Professionals)
One of the best lawyers in the field of IP-Law in Germany
Handelsblatt & Best Lawyers 2020
News
LUTZ | ABEL advises AlphaPet Ventures in equity financing and acquisition
AlphaPet Ventures GmbH secures equity financing led by capiton AG and acquires Healthfood24.LUTZ | ABEL advises Munich based premium pet food company AlphaPet Ventures in both equity financing and acquisition.
The LUTZ | ABEL team led by Dr. Marco Eickmann and Philipp Hoene (both M&A/VC, Munich) included Dr. Sebastian Sumalvico (M&A/VC, Munich), Frank Hahn (M&A/VC, Hamburg), Dr. Marius Mann (Commercial, Stuttgart), Dr. André Schmidt (IP/IT, Hamburg), Claudia Knuth (Employment, Hamburg) and Sebastian Schreiber (Real Estate, Hamburg).
The transaction is subject to pending merger control approval.
-
LUTZ | ABEL advises in EUR 17 Million Series B round of financing for Temedica
The healthcare start-up Temedica GmbH from Germany announced to have completed a € 17 million Series B financing round.The financing round was led by different MIG-Fonds, Santo Venture Capital, G+J Digital Ventures, Salvia and Bernd Wendeln as investors. LUTZ | ABEL advised on the transaction.
The German healthcare start-up Temedica GmbH, which is based in Munich and was founded by Gloria Seibert and Clemens Kofler, closed a € 17 million Series B financing round. MIG-Fonds, Santo Venture Capital and Salvia lead the round – existing shareholders like G+J Digital Ventures and Bernd Wendeln were additional investors.
Founded in 2016, the start-up develops digital companions (such as apps) to support patients in their healing process and to improve their medical care. Until today Temedica came up with the products pelvina (to strengthen the pelvic base), Mineo (to strengthen the back) as well as Waya (for a healthy nutrition and motion sequence). Further product developments are in the process of planning.
The LUTZ | ABEL team included the following attorneys: The partners Dr. Bernhard Noreisch (Munich) and Dr. Lorenz Jellinghaus (Hamburg) led the transaction. The team further consisted of Claudia Knuth (Labour Law, Hamburg), Andreas Kössel (Labour Law, Munich), Jan-Phillip Kunz (VC, Munich), Nina Sophie Osten (VC, Hamburg), Dr. Cornelius Renner (IT, Data Protection Law, Berlin), Ute Schenn (Commercial, Stuttgart), Dr. André Schmidt (IT, Data Protection Law, Hamburg).
The investors Santo Venture Capital and Salvia were represented by honert + partner (Sven Fritsche, Munich).
